A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented at the European Academy of Neurology (EAN) Congress 2025 A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented at the European Academy of Neurology (EAN) Congress 2025 A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented at the European Academy of Neurology (EAN) Congress 2025
The arginine substitution and extended N-terminus confer reduced affinity for IGFBPs, allowing greater bioavailability and receptor interaction
On June 6, 2024, the litigation was handed over to U.S
Plan de supplmentation couramment utilis : 1 g avant lentranement
Y semaglutida, que es el nuevo semanal, el nombre comercial es Ozempic en diabetes tipo II, que es de donde viene toda la polmica y el desabastecimiento, mientras que en obesidad se llama Wegovy que ese s lleva un ao comercializado en Estados Unidos
A cellular perspective on brain energy metabolism and functional imaging